RT @ESCAIDE: So, what do #ESCAIDE2022 participants think about the conference?
We asked @CarinaBrehony, @hbrabies & @drnomesboxall to share their thoughts about day one of the #ESCAIDE conference.
RT @Eurosurveillanc: A new 𝘌𝘶𝘳𝘰𝘴𝘶𝘳𝘷𝘦𝘪𝘭𝘭𝘢𝘯𝘤𝘦 issue is out including an editorial by Pierre Delsaux, @EC_HERA on how the newly established authority will help prepare Europe for future health threats and crises
🗞️ https://www.eurosurveillance.org/content/eurosurveillance/27/47
There are high concerns that new emerging #Omicron subvariants are escaping neutralisation by available monoclonal antibody medicines against #COVID19. We will review all available data to issue new recommendations to healthcare professionals. #EMAPresser
EMA's regular press briefing on public health emergencies https://nitter.eu/i/broadcasts/1jMJgLMdkEYxL
Nearly all children are infected by #RSV by the age of two years, and reinfections are common.
Although infection is nearly unavoidable most children, special efforts should nevertheless be made to protect preterm babies and infants younger than six months old.
#RSV can also cause serious complications and deaths among adults, particularly those aged 65 years and older.
Hospitalisations for adults in the EU, Norway and the United Kingdom are on average 158 000 per year.
Worldwide, the #RSV virus is estimated to cause 33 million cases and 66 000 to 199 000 deaths of children below five years every year.
In the EU, Norway and the United Kingdom, RSV causes an average of 213 000 annual hospitalisations in children under five years.
Respiratory syncytial virus (#RSV) is a seasonal virus that recurs throughout the year in Europe with peaks mainly during the autumn, winter, and spring months (October to April), and is a leading cause of acute lower respiratory tract infections in infants and young children.
#RSV virus expected to add pressure on hospitals in many EU/EEA countries this season.
Thirteen EU/EEA Member States have reported a rise in RSV cases between October and 14 November 2022.
Full press release: https://www.ecdc.europa.eu/en/news-events/rsv-virus-expected-add-pressure-hospitals-many-eueea-countries-season
RT @emcdda: 🤝🔛 @ECDC_EU's Janelle Sandberg and EMCDDA's Thomas Seyler will be in N3 at 13.20 to discuss the #prevention and control of #infectiousdiseases among people who inject drugs #LxAddictions22
https://www.lisbonaddictions.eu/lisbon-addictions-2022/sessions/prevention-and-control-infectious-diseases-among-people-who-inject-drugs-new-evidence
RT @ESCAIDE: Enjoying #ESCAIDE this year?
Tweet about it! :)
We have created a dedicated #TwitterWall that will be displayed at the venue (and can be viewed online of course as well).
Just post your thoughts with #ESCAIDE2022 and see them popping up here: https://my.walls.io/ESCAIDE2022
RT @EMA_News: #DidYouKnow? Regulators around the world made collaboration to prevent and combat #AMR a key priority.
❗ Read this statement: https://www.icmra.info/drupal/sites/default/files/2019-11/ICMRA_Antimicrobial_Resistance.pdf
RT @ESCAIDE: We are ready.
Are you?
Starting the #ESCAIDE2022 conference strong with the first plenary session - „Controlling a #pandemic what are the ethical boundaries” - with @alena_buyx, moderated by @ECDC_EU director - Dr Andrea Ammon.
Register to watch #Live:
https://www.escaide.eu/en/registration
#EuropeanTestingWeek is on!
Testing saves lives and is crucial in the fight with the #HIV/#AIDS epidemic!
Want to know why?
Want to join the campaing?
Follow our @ECDC_HIVAIDS account and @EuroTestWeek for more info!
#EuroTestWeek
⬇️⬇️⬇️
RT @ECDC_HIVAIDS: #EuroTestWeek is on!
Testing saves lives and is vital for ending the #HIV/#AIDS epidemic and combatting #hepatitis, for timely treatment and care!
Our annual #ESCAIDE conference starts tomorrow!
Don't miss the chance to listen, discuss and network!
You can still register for the online participation in #ESCAIDE2022!
And believe us, it's worth it! :)
⬇️⬇️⬇️
RT @ESCAIDE: #ESCAIDE2022 starts tomorrow!
All registered participants can now access the conference platform here: https://app.swapcard.com/event/escaide2022
Log in with your registration email, update your profile and explore what is coming up!
#ESCAIDE
RT @Eurosurveillanc: New technology offers a variety of cost-effective rapid testing kits to improve access to testing
This perspective explores upsides, implications & necessary steps for the use of platforms for multi-disease testing for #TB #HIV #HCV #STI
⬇️
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.29.2100930
#EuroTestWeek
Unofficial automated mirror. No copyright asserted. ∎ The European Centre for Disease Prevention and Control. We aim to strengthen #Europe's defences against infectious diseases.